1zdu: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1zdu" size="450" color="white" frame="true" align="right" spinBox="true" caption="1zdu, resolution 2.50Å" /> '''The Crystal Structu...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1zdu.gif|left|200px]]<br />
[[Image:1zdu.gif|left|200px]]<br /><applet load="1zdu" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1zdu" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1zdu, resolution 2.50&Aring;" />
caption="1zdu, resolution 2.50&Aring;" />
'''The Crystal Structure of Human Liver Receptor Homologue-1'''<br />
'''The Crystal Structure of Human Liver Receptor Homologue-1'''<br />


==Overview==
==Overview==
Steroidogenic factor-1 (SF-1) and liver receptor homologue-1 (LRH-1), belong to the fushi tarazu factor 1 subfamily of nuclear receptors. SF-1, is an essential factor for sex determination during development and, regulates adrenal and gonadal steroidogenesis in the adult, whereas LRH-1, is a critical factor for development of endodermal tissues and regulates, cholesterol and bile acid homeostasis. Regulatory ligands are unknown for, SF-1 and LRH-1. A reported mouse LRH-1 structure revealed an empty pocket, in a region commonly occupied by ligands in the structures of other, nuclear receptors, and pocket-filling mutations did not alter the, constitutive activity observed. Here we report the crystal structures of, the putative ligand-binding domains of human SF-1 at 2.1-A resolution and, human LRH-1 at 2.5-A resolution. Both structures bind a, coactivator-derived peptide at the canonical activation-function surface, thus adopting the transcriptionally activating conformation. In human, LRH-1, coactivator peptide binding also occurs to a second site. We, discovered in both structures a phospholipid molecule bound in a pocket of, the putative ligand-binding domain. MS analysis of the protein samples, used for crystallization indicated that the two proteins associate with a, range of phospholipids. Mutations of the pocket-lining residues reduced, the transcriptional activities of SF-1 and LRH-1 in mammalian cell, transfection assays without affecting their expression levels. These, results suggest that human SF-1 and LRH-1 may be ligand-binding receptors, although it remains to be seen if phospholipids or possibly other, molecules regulate SF-1 or LRH-1 under physiological conditions.
Steroidogenic factor-1 (SF-1) and liver receptor homologue-1 (LRH-1) belong to the fushi tarazu factor 1 subfamily of nuclear receptors. SF-1 is an essential factor for sex determination during development and regulates adrenal and gonadal steroidogenesis in the adult, whereas LRH-1 is a critical factor for development of endodermal tissues and regulates cholesterol and bile acid homeostasis. Regulatory ligands are unknown for SF-1 and LRH-1. A reported mouse LRH-1 structure revealed an empty pocket in a region commonly occupied by ligands in the structures of other nuclear receptors, and pocket-filling mutations did not alter the constitutive activity observed. Here we report the crystal structures of the putative ligand-binding domains of human SF-1 at 2.1-A resolution and human LRH-1 at 2.5-A resolution. Both structures bind a coactivator-derived peptide at the canonical activation-function surface, thus adopting the transcriptionally activating conformation. In human LRH-1, coactivator peptide binding also occurs to a second site. We discovered in both structures a phospholipid molecule bound in a pocket of the putative ligand-binding domain. MS analysis of the protein samples used for crystallization indicated that the two proteins associate with a range of phospholipids. Mutations of the pocket-lining residues reduced the transcriptional activities of SF-1 and LRH-1 in mammalian cell transfection assays without affecting their expression levels. These results suggest that human SF-1 and LRH-1 may be ligand-binding receptors, although it remains to be seen if phospholipids or possibly other molecules regulate SF-1 or LRH-1 under physiological conditions.


==About this Structure==
==About this Structure==
1ZDU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with P3A and TRS as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1ZDU OCA].  
1ZDU is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=P3A:'>P3A</scene> and <scene name='pdbligand=TRS:'>TRS</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ZDU OCA].  


==Reference==
==Reference==
Line 15: Line 14:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Eng, K.]]
[[Category: Eng, K.]]
[[Category: Krupka, H.I.]]
[[Category: Krupka, H I.]]
[[Category: Marimuthu, A.]]
[[Category: Marimuthu, A.]]
[[Category: Mehra, U.]]
[[Category: Mehra, U.]]
[[Category: Milburn, M.V.]]
[[Category: Milburn, M V.]]
[[Category: Nguyen, H.]]
[[Category: Nguyen, H.]]
[[Category: Powell, B.]]
[[Category: Powell, B.]]
Line 25: Line 24:
[[Category: Tabrizizad, M.]]
[[Category: Tabrizizad, M.]]
[[Category: Wang, W.]]
[[Category: Wang, W.]]
[[Category: West, B.L.]]
[[Category: West, B L.]]
[[Category: Zhang, C.]]
[[Category: Zhang, C.]]
[[Category: P3A]]
[[Category: P3A]]
Line 35: Line 34:
[[Category: phospholipid]]
[[Category: phospholipid]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:33:03 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:14:36 2008''